Hypersomnia
24
1
2
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
2 terminated out of 24 trials
85.7%
-0.8% vs benchmark
4%
1 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (24)
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
RECOVER-SLEEP: Platform Protocol
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
Disentangling the Role of Depression in Hypersomnia
Analysis of New Salivary Biomarkers to Evaluate Excessive Diurnal Sleepiness in Children With Hypersomnia
The Healthy Patterns Sleep Study
Feasibility Study of At-Home EEG Monitoring for Hypersomnia
A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
Patient Outcomes in Unattended and In- Lab Polysomnography
A Multi-Signal Based Monitoring System for CNS Hypersomnias
Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy
Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)
The Music, Sleep and Dementia Study
Telemedicine and Humidification for Cpap IN Osas Key Treatment (THINK Study)
Sleep in Psychiatric Inpatients
Flumazenil for the Treatment of Primary Hypersomnia
Clarithromycin for the Treatment of Hypersomnia
Sleep Disorders of Patients With Diseases of the Nervous System
Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder